Cited by 394Computational Drug Discovery MethodsSynthesis and Characterization of Heterocyclic CompoundsChemical Synthesis and Analysis

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Chemical substructures that enrich for biological activity

Open access

Klekota, Justin, Roth, Frederick P.·2008·Bioinformatics

DOI 10.1093/bioinformatics/btn479PMC PMC2732283

Open this paper in CoChat — free account

Abstract

Motivation: Certain chemical substructures are present in many drugs. This has led to the claim of ‘privileged’ substructures which are predisposed to bioactivity. Because bias in screening library construction could explain this phenomenon, the existence of privilege has been controversial. Results: Using diverse phenotypic assays, we defined bioactivity for multiple compound libraries. Many substructures were associated with bioactivity even after accounting for substructure prevalence in the library, thus validating the privileged substructure concept. Determinations of privilege were confirmed in independent assays and libraries. Our analysis also revealed ‘underprivileged’ substructures and ‘conditional privilege’—rules relating combinations of substructure to bioactivity. Most previously reported substructures have been flat aromatic ring systems. Although we validated such substructures, we also identified three-dimensional privileged substructures. Most privileged substructures display a wide variety of substituents suggesting an entropic mechanism of privilege. Compounds containing privileged substructures had a doubled rate of bioactivity, suggesting practical consequences for pharmaceutical discovery. Contact: fritz_roth@hms.harvard.edu Supplementary information: Supplementary data are available at Bioinformatics online.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/bioinformatics/btn479

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
Horton, D. A., Bourne, G. T., & Smythe, M. L. (2003) · Chemical Reviews · doi:10.1021/cr020033s · Cited by 3,032
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,501
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,752
Proceedings of the 20th conference on Uncertainty in artificial intelligence
Meek, C., Chickering, M., & Halpern, J. Y. (2004) · Cited by 1,548
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
Evans, B., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Lundell, G. F., Veber, D. F., Anderson, P., Chang, R. S. L., et al. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00120a002 · Cited by 1,460
A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress
Boyce, M., Bryant, K. F., Jousse, C., Long, K., Harding, H. P., Scheuner, D. L., Kaufman, R. J., Ma, D., Coen, D. M., Ron, D., et al. (2005) · Science · doi:10.1126/science.1101902 · Cited by 1,403
π-Stacking Interactions
McGaughey, G. B., Gagné, M., & Rappé, A. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15458 · Cited by 1,163
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,048
RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry
Lewell, X. Q., Judd, D. B., Watson, S. P., & Hann, M. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970429i · Cited by 695
Privileged Structures: Applications in Drug Discovery
DeSimone, R., Currie, K., Mitchell, S. A., Darrow, J. W., & Pippin, D. A. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328544 · Cited by 579
Predicting drug sensitivity and resistance
Szakács, G., Annereau, J., Lababidi, S., Shankavaram, U. T., Arciello, A., Bussey, K. J., Reinhold, W. C., Guo, Y., Kruh, G. D., Reimers, M., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.026 · Cited by 545
Learning Bayesian Networks with Local Structure
Friedman, N., & Goldszmidt, M. (1998) · Springer eBooks · doi:10.1007/978-94-011-5014-9_15 · Cited by 400
Mining Graph Data
Cook, D. J., & Holder, L. B. (2006) · Wiley-Interscience eBooks · Cited by 396
Privileged Molecules for Protein Binding Identified from NMR-Based Screening
Hajduk, P. J., Bures, M. G., Praestgaard, J., & Fesik, S. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000164q · Cited by 353
Small Molecule Regulators of Protein Arginine Methyltransferases
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 344
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
Patchett, A. A., Nargund, R. P., Tata, J. R., Chen, M. H., Barakat, K. J., Johnston, D. B., Cheng, K., CHAN, W. W.-S., Butler, B., & Hickey, G. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7001 · Cited by 328
Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation
Le, N. T. V., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-05-1866 · Cited by 321
Chapter 26. Privileged structures — An update
Patchett, A. A., & Nargund, R. P. (2000) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(00)35027-8 · Cited by 304
Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis
Haggarty, S. J., Mayer, T. U., Miyamoto, D. T., Fathi, R., King, R. W., Mitchison, T. J., & Schreiber, S. L. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00101-0 · Cited by 251
Mining Graph Data
(2006) · Wiley eBooks · doi:10.1002/0470073047 · Cited by 229
A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth
Fantin, V. R., Berardi, M. J., Scorrano, L., Korsmeyer, S. J., & Leder, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00082-x · Cited by 228
Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI
Nieland, T. J. F., Penman, M., Dori, L., Krieger, M., & Kirchhausen, T. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222421399 · Cited by 216
Medicinal chemistry of target family-directed masterkeys
Müller, G. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02781-8 · Cited by 209
Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning
Rusinko, A., Farmen, M. W., Lambert, C. G., Brown, P. L., & Young, S. S. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9903049 · Cited by 187
Recognition of Privileged Structures by G-Protein Coupled Receptors
Bondensgaard, K., Ankersen, M., Thøgersen, H., Hansen, B. S., Wulff, B. S., & Bywater, R. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0309452 · Cited by 182
Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification
Shearer, M. J. (2000) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200011000-00004 · Cited by 180
Exo1: A new chemical inhibitor of the exocytic pathway
Feng, Y., Yu, S. S. B., Lasell, T. K. R., Jadhav, A. P., Macia, E., Chardin, P., Melançon, P., Roth, M. G., Mitchison, T. J., & Kirchhausen, T. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631766100 · Cited by 170
The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents III: The Effect of the Ligands on Molecular Targets Involved in Proliferation
Darnell, G. A., & Richardson, D. R. (1999) · Blood · doi:10.1182/blood.v94.2.781 · Cited by 168
The Receptors : a comprehensive treatise
O'Brien, R. D. (1979) · Medical Entomology and Zoology · Cited by 145
Predicting Gene Function From Patterns of AnnotationPreprint
King, O. D., Foulger, R. E., Dwight, S. S., White, J. V., & Roth, F. P. (2003) · Genome Research · doi:10.1101/gr.440803 · Cited by 145
Self-citation
Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features
Wagener, M., & van Geerestein, V. J. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990266t · Cited by 138
Screening for Cell Migration Inhibitors via Automated Microscopy Reveals a Rho-Kinase Inhibitor
Yarrow, J. C., Totsukawa, G., Charras, G., & Mitchison, T. J. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.01.015 · Cited by 135
JChem: Java Applets and Modules Supporting Chemical Database Handling from Web Browsers
Csizmadia, F. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9902696 · Cited by 122
Phenotypic Screening of Small Molecule Libraries by High Throughput Cell Imaging
Yarrow, J. C., Feng, Y., Perlman, Z. E., Kirchhausen, T. L., & Mitchison, T. J. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298527 · Cited by 119
Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain.
Sangameswaran, L., Fales, H. M., Friedrich, P., & Blas, A. L. D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9236 · Cited by 115
Systems, Man and Cybernetics, 2004 IEEE International Conference on
Arnott, J. L., Khairulla, Z., Dickinson, A., Syme, A., Alm, N., Eisma, R., & Gregor, P. (2004) · Cited by 110
Exploring privileged structures: the combinatorial synthesis of cyclic peptides
Horton, D. A., Bourne, G. T., & Smythe, M. L. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020863921840 · Cited by 102
Protein β-turn mimetics I. Design, synthesis, and evaluation in model cyclic peptides.
Ripka, W. C., Lucca, G. V. D., Bach, A., Pottorf, R. S., & Blaney, J. M. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)90217-0 · Cited by 98
The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1
Liang, S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg116 · Cited by 85
A Structural Model for the Open Conformation of the mdr1 P-glycoprotein Based on the MsbA Crystal Structure
Seigneuret, M., & Garnier‐Suillerot, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302443200 · Cited by 59
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent
Dinnell, K., Chicchi, G. G., Dhar, M. J., Elliott, J. M., Hollingworth, G. J., Kurtz, M. M., Ridgill, M. P., Rycroft, W., Tsao, K.-L. C., Williams, A. R., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00183-4 · Cited by 58
Benzodiazepine peptidomimetic inhibitors of farnesyltransferase
Marsters, J. C., McDowell, R. S., Reynolds, M. E., Oare, D. A., Somers, T. C., Stanley, M. S., Rawson, T. E., Struble, M. E., Burdick, D. J., Chan, K. S., et al. (1994) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)82044-1 · Cited by 51
Analysis of a 29 Full Factorial Chemical Library
Young, S. S., & Hawkins, D. M. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00014a030 · Cited by 48
Molecular conformation and biological activity of central nervous system active drugs
Andrews, P. R., & Lloyd, E. J. (1982) · Medicinal Research Reviews · doi:10.1002/med.2610020404 · Cited by 47
Mechanism of diphacinone rodenticide toxicosis in the dog and its therapeutic implications
Mount, M. E., & Feldman, B. F. (1983) · American Journal of Veterinary Research · doi:10.2460/ajvr.1983.44.11.2009 · Cited by 45
Frequent graph mining and its application to molecular databases
Nijssen, S., & Kok, J. N. (2005) · Conference proceedings/Conference proceedings - IEEE International Conference on Systems, Man, and Cybernetics · doi:10.1109/icsmc.2004.1401252 · Cited by 45
Combinatorial synthesis of 3-(Amidoalkyl) and 3-(Aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors
Willoughby, C. A., Hutchins, S. M., Rosauer, K. G., Dhar, M. J., Chapman, K. T., Chicchi, G. G., Sadowski, S. J., Weinberg, D. H., Patel, S. S., Malkowitz, L., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00665-5 · Cited by 44
Finding Multiactivity Substructures by Mining Databases of Drug-Like Compounds
Sheridan, R. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci030004y · Cited by 34
Use of Recursion Forests in the Sequential Screening Process: Consensus Selection by Multiple Recursion Trees
van Rhee, A. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034023j · Cited by 32
Solid-Phase Synthesis of Libraries Generated from a 4-Phenyl-2-carboxy-piperazine Scaffold
Nilsson, J. W., Thorstensson, F., Kvarnström, I., Oprea, T. I., Samuelsson, B., & Nilsson, I. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc010013o · Cited by 27
Confirmation of Indandione Rodenticide Toxicoses by Mass Spectrometry/Mass Spectrometry
Braselton, W. E., Neiger, R. D., & Poppenga, R. H. (1992) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063879200400413 · Cited by 26
Optimization of Focused Chemical Libraries Using Recursive Partitioning
Rusinko, A. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207024607383 · Cited by 25
Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors
Heinelt, U., Herok, S., Matter, H., & Wildgoose, P. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00631-4 · Cited by 15
Identifying Biologically Active Compound Classes Using Phenotypic Screening Data and Sampling Statistics
Klekota, J., Brauner, E., & Schreiber, S. L. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050087d · Cited by 15
Self-citation
Evaluating the ability of CASE, an artificial intelligence structure—activity relational system, to predict structural alerts for genotoxicity
Rosenkranz, H. S., & Klopman, G. (1990) · Mutagenesis · doi:10.1093/mutage/5.6.525 · Cited by 13
ChemInform Abstract: Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features.
Wagener, M., & van Geerestein, V. J. (2000) · ChemInform · doi:10.1002/chin.200024236 · Cited by 6
Probing adenosine and P2 receptors: Design of novel purines and nonpurines as selective ligands
Jacobson, K. A. (2001) · Drug Development Research · doi:10.1002/ddr.1113 · Cited by 5
Untitled work
(2002) · doi:10.1002/1439-7633(20021004)3:10

Flagged first, then by citations

2 of the 62 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Patchett, 2000, Privileged structures – an update, Annu. Rep. Med. Chem, 35, 289

Sorted by citations

PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints
Yap, C. W. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21707 · Cited by 2,979
Searching molecular structure databases with tandem mass spectra using CSI:FingerID
Dührkop, K., Shen, H., Meusel, M., Rousu, J., & Böcker, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509788112 · Cited by 1,190
Systematic classification of unknown metabolites using high-resolution fragmentation mass spectra
Dührkop, K., Nothias, L.-F., Fleischauer, M., Reher, R., Ludwig, M., Hoffmann, M. A., Petras, D., Gerwick, W. H., Rousu, J., Dorrestein, P. C., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0740-8 · Cited by 860
Molecular fingerprint similarity search in virtual screening
Cereto‐Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcı́a-Vallvé, S., & Pujadas, G. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.005 · Cited by 881
Machine-learning approaches in drug discovery: methods and applications
Lavecchia, A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.012 · Cited by 822

See all 394

Authors: Klekota, J., & Roth, F. P.
Affiliations: Harvard University (US)
Corresponding author: Roth, Frederick P.
ORCID: Roth, Frederick P.
Venue: Bioinformatics
Publisher: Oxford University Press (OUP)
Published: 2008-09-11
Volume: 24
Issue: 21
Pages: 2518-2525
ISSN: 1367-4803 (ISSN-L)
1367-4811
DOI: 10.1093/bioinformatics/btn479
PMC: PMC2732283
OpenAlex: W2107081909
Cited by: 392
References: 62
Citations by year: 2026: 27 · 2025: 28 · 2024: 43 · 2023: 37 · 2022: 24 · 2021: 22 · 2020: 22 · 2019: 18 · 2018: 34 · 2017: 27 · 2016: 31 · 2015: 22 · 2014: 17 · 2013: 13 · 2012: 14
FWCI: 5.66
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/2.0/uk/ (vor, 2943 d)
Locations: Bioinformatics (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders: Centre National de la Recherche Scientifique
National Institute on Aging (R01AG017115)
National Heart, Lung, and Blood Institute (U01HL081341)
National Human Genome Research Institute (R01 HG0017115, R01HG003224, P50HG004233)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords: chemical substructures, bioactivity prediction, chemical libraries, phenotypic assays, aromatic ring systems, drug discovery, structure-activity relationship
MeSH terms: Animals, Cells, Cultured, Pharmaceutical Preparations, Humans, Ligands, Structure-Activity Relationship, Drug Design, Databases, Factual, Combinatorial Chemistry Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chemical substructures that enrich for biological activity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks